Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Inflammatory Breast Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1

Interventions

Vincristine 2Radiotherapy 2Melphalan 2Ifosfamide 2Etoposide 2Doxorubicin 2Dactinomycin 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1aldesleukin 1Methylprednisolone 1Mesna 1Magnetic Resonance Spectroscopy 1Gene Expression Profiling 1Gelclair 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive, Peripheral × Mesna × Clear all
NCT00002516 2013-09-17

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡